Cancer stem cells in malignant glioma - The mechanism of cancer initiation and the therapeutic development

Neurological Surgery

Volumn 38, Issue 10, 2010, Pages 879-889

  Nakano, Ichiro ^a   Saya, Hideyuki ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Microrecording; Stereotactic surgery; Thalamus; Tremor

Indexed keywords

AFLIBERCEPT; AMG 102; AP 12009; BEVACIZUMAB; CEDIRANIB; CETUXIMAB; DASATINIB; ENZASTAURIN; ERLOTINIB; EVEROLIMUS; GEFITINIB; IMATINIB; LAPATINIB; N [4 (3 CHLORO 4 FLUOROANILINO) 7 (TETRAHYDRO 3 FURYLOXY) 6 QUINAZOLINYL] 4 DIMETHYLAMINO 2 BUTENAMIDE; NIMOTUZUMAB; PAZOPANIB; RAPAMYCIN; ROMIDEPSIN; SORAFENIB; SUNITINIB; TANDUTINIB; TEMSIROLIMUS; VALPROIC ACID; VANDETANIB; VATALANIB; VORINOSTAT; XL 184;

BREAST CANCER; CANCER GENE THERAPY; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER STEM CELL; CANCER SURVIVAL; CELL HETEROGENEITY; DISEASE SEVERITY; EPIGENETICS; GLIOBLASTOMA; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LEUKEMIA; MELANOMA; NONHUMAN; PROGNOSIS; REVIEW;

GLIOMA; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASTIC STEM CELLS;

EID: 78049329874     PISSN: 03012603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Altman J : Autoradiographic investigation of cell proliferation in the brains of rats and cats. Anat Rec 145 : 573-591, 1963
2. Copeland DD, Vogel FS, Bigner DD : The induction of intractranlal neoplasms by the inoculation of avian sarcoma virus in perinatal and adult rats. J Neuropathol Exp Neurol 34 : 340-358, 1975
3. Bonnet D, Dick JE : Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3 : 730-737, 1997 (Pubitemid 27298715)
4. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF : Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100 : 3983-3988, 2003 (Pubitemid 36418143)
5. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Komblum HI : Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A 100 : 15178-15183, 2003
6. Singh SK, Clarke ID, Terasakl M, Bonn VE, Hawkins C, Squire J, Dirks PB : Identification of a cancer stem cell in human brain tumors. Cancer Res 63 : 5821-5828, 2003
7. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB : Identification of human brain tumour initiating cells. Nature 432 : 396-401, 2004 (Pubitemid 39551674)
8. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ : Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65 : 10946-10951, 2005
9. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M : A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65 : 9328-9337, 2005
10. Dufour C, Cadusseau J, Varlet P, Surena AL, de Faria GP, Dias-Morals A, Auger N, Léonard N, Daudigeos E, Dantas-Barbosa C, Grill J, Lazar V, Dessen P, Vassal G, Prevot V, Sharif A, Chneiweiss H, Junier MP : Astrocytes reverted to a neural progenitor-like state with transforming growth factor alpha are sensitized to cancerous transformation. Stem Cells 27 : 2373-2382, 2009
11. Kang SK, Park JB, Cha SH : Multipotent, dedifferentiated cancer stem-like cells from brain gliomas. Stem Cells Dev 15 : 423-435, 2006
12. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW : An integrated genomic analysis of human glioblastoma multiforme. Science 321 : 1807-1812, 2008
13. Parmigiani G, Boca S, Lin J, Kinzler KW, Velculescu V, Vogelstein B : Design and analysis issues in genome-wide somatic mutation studies of cancer. Genomics 93 : 17-21, 2009
14. Levi BP, Morrison SJ : Stem cells use distinct self-renewal programs at different ages. Cold Spring Harb Symp Quant Biol 73 : 539-553, 2008
15. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ : Efficient tumour formation by single human melanoma cells. Nature 456 : 593-598, 2008
16. Morrison SJ, Spradllng AC : Stem cells and niches : mechanisms that promote stem cell maintenance throughout life. Cell 132 : 598-611, 2008
17. Pardal R, Molofsky AV, He S, Morrison SJ : Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors. Cold Spring Harb Symp Quant Biol 70 : 177-185, 2005
18. Morrison SJ : Cancer stem cells. Clin Adv Hematol Oncol 3 : 171-172, 2005
19. Nakano I, Komblum HI : Methods for analysis of brain tumor stem cell and neural stem cell self-renewal. Methods Mol Biol 568 : 37-56, 2009
20. Read TA, Fogarty MP, Markant SL, McLendon RE, Wei Z, Ellison DW, Febbo PG, Wechsler-Reya RJ : Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell 15 : 135-147, 2009
21. ) Dirks PB : Brain tumor stem cells : bringing order to the chaos of brain cancer. J Clin Oncol 26 : 2916-2924, 2008
22. Park DM, Rich JN : Biology of glioma cancer stem cells. Mol Cells 28 : 7-12, 2009
23. Singh SK, Clarke ID, Hide T, Dirks PB : Cancer stem cells in nervous system tumors. Oncogene 23 : 7267-7273, 2004 (Pubitemid 39382160)
24. Li Z, Wang H, Eyler CE, Hjelmeland AB, Rich JN : Turning cancer stem cells inside out : an exploration of glioma stem cell signaling pathways. J Biol Chem 284 : 16705-16709, 2009
25. Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN : Targeting cancer stem cells through LlCAM suppresses glioma growth. Cancer Res 68 : 6043-6048, 2008
26. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN : Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 : 756-760, 2006
27. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, Aigner L, Brawanski A, Bogdahn U, Beier CP : CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67 : 4010-4015, 2007
28. Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, Greve JM, Soriano RH, Gilmour LL, Rivers CS, Modrusan Z, Nacu S, Guerrero S, Edgar KA, Wallin JJ, Lamszus K, Westphal M, Heim S, James CD, VandenBerg SR, Costello JF, Moorefield S, Cowdrey CJ, Prados M, Phillips HS : A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 17 : 362-375, 2010
29. Grlguer CE, Oliva CR, Gobin E, Marcorelles P, Benos DJ, Lancaster JR Jr, Gillespie GY : CD133 is a marker of bioenergetic stress in human glioma. PLoS One 3 : e3655, 2008
30. Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, Macswords J, Wu Q, Vasanji A, McLendon RE, Hjelmeland AB, Rich JN : Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6 : 421-432, 2010
31. Harris MA, Yang H, Low BE, Mukherjee J, Guha A, Branson RT, Shultz LD, Israel MA, Yun K : Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res 68 : 10051-10059, 2008
32. Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, Matsul W, Piccirillo S, Vescovl AL, DiMeco F, Olivi A, Eberhart CG : Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25 : 2524-2533, 2007
33. Gilbertson RJ, Rich JN : Making a tumour's bed : glioblastoma stem cells and the vascular niche. Nat Rev Cancer 7 : 733-736, 2007
34. Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S, Shi Q, Cao Y, Lathia J, McLendon RE, Hjelmeland AB, Rich JN : Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15 : 501-513, 2009
35. Northcott PA, Fernandez-L A, Hagan JP, Ellison DW, Grajkowska W, Gillespie Y, Grundy R, Van Meter T, Rutka JT, Croce CM, Kenney AM, Taylor MD : The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res 69 : 3249-3255, 2009
36. Xu Q, Yuan X, Liu G, Black KL, Yu JS : Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas. Stem Cells 26 : 3018-3026, 2008
37. Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW, Holland EC : PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4 : 226-235, 2009
38. Wick W, Weller M, van den Bent M, Stupp R : Bevaclzumab and recurrent malignant gliomas : a European perspective. J Clin Oncol 28 : 188-189 ; author reply e190-192, 2010
39. Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Marcello J, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Wagner M, Bailey L, Bigner DD, Friedman AH, Friedman HS : Bevaclzumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25 : 4722-4729, 2007
40. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD, Rich JN : Stem cell-like glioma cells promote tumor anglogenesis through vascular endothelial growth factor. Cancer Res 66 : 7843-7848, 2006
41. Chen W, Delaloye S, Silverman DH, Geist C, Czemin J, Sayre J, Satyamurthy N, Pope W, Lai A, Phelps ME, Cloughesy T : Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography : a pilot study. J Clin Oncol 25 : 4714-4721, 2007
42. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG : NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 28 : 5-16, 2010
43. Kessler JD, Hasegawa H, Brun SN, Emmenegger BA, Yang ZJ, Dutton JW, Wang F, Wechsler-Reya RJ : N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma. Genes Dev 23 : 157-170, 2009
44. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A : : HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 17 : 165-172, 2007 (Pubitemid 46107823)
45. Kean S : Medicine. Disrupting Hedgehog may reverse advanced cancer, if only temporarily. Science 325 : 1188, 2009
46. Yauch RL, Dijkgraaf GJ, Alicke B, Januario T, Ahn CP, Holcomb T, Pujara K, Stinson J, Callahan CA, Tang T, Bazan JF, Kan Z, Seshaglri S, Hann CL, Gould SE, Low JA, Rudin CM, de Sauvage FJ : Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326 : 572-574, 2009
47. Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, LoRusso PM, Von Hoff DD, de Sauvage FJ, Low JA : Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 361 : 1173-1178, 2009
48. Tamase A, Muraguchi T, Naka K, Tanaka S, Kinoshita M, Hoshii T, Ohmura M, Shugo H, Ooshio T, Nakada M, Sawamoto K, Onodera M, Matsumoto K, Oshima M, Asano M, Saya H, Okano H, Suda T, Hamada J, Hirao A : Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin. Proc Natl Acad Sci U S A 106 : 17163-17168, 2009